BCM
TMO icon

Brookstone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Brookstone Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300
Closed -$182K – 853
2021
Q4 		$182K Buy
+300
New +$187K ﹤0.01% 722

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Brookstone Capital Management's TMO Position: Q2 2026 in Review

Brookstone Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 77% in Q2 2026, selling an estimated $3.12M and leaving 1,980 shares worth $993K. The position accounts for 0.01% of the portfolio, ranked #700.

Brookstone Capital Management first reported a position in TMO in Q2 2015 and has held it in 34 quarters since. The position peaked at $4.95M in Q4 2025. 1,603 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Brookstone Capital Management held 1,980 shares of Thermo Fisher Scientific worth $993K as of Q2 2026.
  • Brookstone Capital Management sold 6,506 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.12M.
  • Thermo Fisher Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #700 holding.
  • Brookstone Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 34 quarters since.
  • Brookstone Capital Management's Thermo Fisher Scientific position peaked at $4.95M in Q4 2025.
  • 1,603 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.